Brainomix announces new partnership with Pixyl to expand its offering with multiple sclerosis solution
OXFORD, England, Nov. 25, 2022 /PRNewswire/ -- Brainomix, an AI-powered medtech solutions company, has announced a new partnership with Pixyl, an award-winning, Grenoble-based medtech specializing in medical neurology imaging. As part of the collaboration, Brainomix will distribute Pixyl's Neuro.MS Software as a Service (SaaS) solution (SaaS), which is used in the diagnosis and treatment of patients with multiple sclerosis.
- As part of the collaboration, Brainomix will distribute Pixyl's Neuro.MS Software as a Service (SaaS) solution (SaaS), which is used in the diagnosis and treatment of patients with multiple sclerosis.
- Pixyl's revolutionary deep-learning technology allows radiologists and clinicians to quickly access clinically relevant information for neurological disorders like multiple sclerosis (MS).
- The CE-marked class IIa product Neuro.MS automatically analyzes brain MRI images to identify, quantify and track abnormalities in under 5 minutes.
- Brainomix will be distributing Pixyl.Neuro SaaS solution exclusively in the UK and Ireland, the Nordics and key markets across Eastern Europe.